1. Home
  2. IFF vs BNTX Comparison

IFF vs BNTX Comparison

Compare IFF & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Flavors & Fragrances Inc.

IFF

International Flavors & Fragrances Inc.

HOLD

Current Price

$65.50

Market Cap

19.6B

Sector

Industrials

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$91.77

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFF
BNTX
Founded
1833
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
24.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
IFF
BNTX
Price
$65.50
$91.77
Analyst Decision
Strong Buy
Buy
Analyst Count
15
11
Target Price
$85.15
$137.40
AVG Volume (30 Days)
2.3M
1.4M
Earning Date
11-04-2025
11-03-2025
Dividend Yield
2.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,072,000,000.00
$3,698,814,972.00
Revenue This Year
N/A
$2.36
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.70
52 Week Low
$59.14
$81.20
52 Week High
$88.09
$129.27

Technical Indicators

Market Signals
Indicator
IFF
BNTX
Relative Strength Index (RSI) 50.15 33.05
Support Level $62.06 $94.52
Resistance Level $67.95 $93.76
Average True Range (ATR) 1.52 2.28
MACD -0.27 -0.40
Stochastic Oscillator 43.81 6.80

Price Performance

Historical Comparison
IFF
BNTX

About IFF International Flavors & Fragrances Inc.

International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: